Bronchial diffusing capacity of nitric oxide is increased in patients with allergic rhinitis

International Archives of Allergy and Immunology

Volumn 148, Issue 2, 2009, Pages 154-160

  Mäkinen, Tarja ^b   Lehtimäki, Lauri ^b   Kinnunen, Hannele ^b   Nieminen, Riina ^b   Kankaanranta, Hannu ^b   Moilanen, Eeva ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NONE

Author keywords

8 Isoprostane; Allergic rhinitis; Breath condensate; Exhaled nitric oxide; Glucocorticosteroids

Indexed keywords

8 ISOPROSTANE; EOSINOPHIL CATIONIC PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID MOMETASONE; IMMUNOGLOBULIN E; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MALE; PRIORITY JOURNAL;

ADULT; BIOLOGICAL MARKERS; BREATH TESTS; BRONCHI; DINOPROST; EOSINOPHIL CATIONIC PROTEIN; FEMALE; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; MALE; NITRIC OXIDE; PREGNADIENEDIOLS; RESPIRATORY FUNCTION TESTS; RHINITIS, ALLERGIC, PERENNIAL; YOUNG ADULT;

EID: 51849154172     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000155746     Document Type: Article

References (44)

1. Alving K, Weitzberg E, Lundberg JM: Increased amounts of nitric oxide in exhaled air of asthmatic patients. Eur Respir J 1993;6:1368-1370.
2. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-135.
3. Corradi M, Majori M, Cacciani G, Consigli G, de'Munari E, Pesci A: Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease. Thorax 1999;54:572-575.
4. Henriksen AH, Sue-Chu M, Lingaas Holmen T, Langhammer A, Bjermer L: Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999;13:301-306.
5. Gratziou C, Rovina N, Lignos M, Vogiatzis I, Roussos CH: Exhaled nitric oxide in seasonal allergic rhinitis: influence of pollen season and therapy. Clin Exp Allergy 2000;31:409-416.
6. Downie SR, Andersson M, Rimmer J, Leuppi JD, Xuan W, Akerlund A, et al: Association between nasal and bronchial symptoms in subjects with persistent allergic rhinitis. Allergy 2004;59:320-326.
7. Kharitonov SA, Yates DH, Barnes PJ: Increased nitric oxide in exhaled air of normal human subjects with upper respiratory tract infections. Eur Respir J 1995;8:295-297.
8. Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in the exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-457.
9. Kharitonov SA, Yates DH, Chung KF, Barnes PJ: Changes in the dose of inhaled steroids affect exhaled nitric oxide levels of asthmatic patients. Eur J Respir Dis 1996;9:196-201.
10. Yates DH, Kharitonov SA, Robbins RA, Thomas PS, Barnes PJ: Effect of nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:892-896.
11. Lehtimäki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E: Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 2001;18:635-639.
12. American Thoracic Society/European Respiratory Society: ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 2005;171:912-930.
13. Tsoukias NM, George SC: A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 1998;85:653-666.
14. Silkoff PE, Sylvester JT, Zamel N, Permutt S: Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000;161:1218-1228.
15. George SC, Hogman M, Permutt S, Silkoff PE: Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004;96:831-839.
16. Lehtimäki L, Turjanmaa V, Kankaanranta H, Saarelainen S, Hahtola P, Moilanen E: Increased bronchial nitric oxide production in patients with asthma measured with a novel method of different exhalation flow rates. Ann Med 2000;32:417-423.
17. Lehtimäki L, Kankaanranta H, Saarelainen S, Hahtola P, Järvenpää R, Koivula T, et al: Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001;163:1557-1561.
18. Lehtonen H, Oksa P, Lehtimäki L, Sepponen A, Nieminen R, Kankaanranta H, et al: Increased alveolar nitric oxide concentration, and high levels of leukotriene B4 and 8-isoprostane in exhaled breath condensate in patients with asbestosis. Thorax 2007;62:602-607.
19. Högman M, Holkvist T, Wegener T, Emtner M, Andersson M, Hedenström H, et al: Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med 2002;96:24-30.
20. Horváth I, Hunt J, Barnes PJ: Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26:523-548.
21. Dohlman AW, Black HR, Royall JA: Expired breath hydrogen peroxide is a marker of acute airway inflammation in pediatric patients with asthma. Am Rev Respir Dis 1993;148:955-960.
22. Emelyanov A, Fedoseev G, Abulimity A, Rudinski K, Fedoulov A, Karabanov A, Barnes PJ: Elevated concentrations of exhaled hydrogen peroxide in asthmatic patients. Chest 2001;120:1136-1139.
23. Montuschi P, Barnes PJ: Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol 2002;109:615-620.
24. Hanazawa T, Kharitonov SA, Barnes PJ: Increased nitrotyrosine in exhaled breath condensate of patients with asthma. Am J Respir Crit Care Med 2000;162:1273-1276.
25. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ: Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999;160:216-220.
26. Corradi M, Montuschi P, Donnelly L, Pesci A, Kharitonov SA, Barnes PJ: Increased nitrosothiols in exhaled breath condensate in inflammatory airway diseases. Am J Respir Crit Care Med 2001;163:854-858.
27. Spergel JM: Atopic march: link to upper airways. Curr Opin Allergy Clin Immunol 2005;5:17-21.
28. Gelfand EW: Inflammatory mediators in allergic rhinitis. J Allergy Clin Immunol 2004;14:135-138.
29. Ciprandi G, Cirillo I, Vizzaccaro A, Milanese M, Tosca MA: Airway function and nasal inflammation in seasonal allergic rhinitis and asthma. Clin Exp Allergy 2004;34:891-896.
30. Kotikoski H, Alajuuma P, Moilanen E, Salmenperä P, Oksala O, Laippala P, et al: Comparison of nitric oxide donors in lowering intraocular pressure in rabbits: role of cyclic GMP. J Ocul Pharmacol Ther 2002;18:11-23.
31. Viljanen A, Halttunen P, Kreus K, Viljanen B: Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest 1982;42(suppl159):5-20.
32. American Thoracic Society: Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991;144:1202-1218.
33. Silkoff PE, McClean PA, Caramori M, Slutsky AS, Zamel N: A significant proportion of exhaled nitric oxide arises in large airways in normal subjects. Respir Physiol 1998;113:33-38.
34. Djukanovic R, Lai CK, Wilson JW, Britten KM, Wilson SJ, Roche WR, et al: Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992;5:538-544.
35. Montuschi P, Kharitonov SA, Ciabattoni G, Corradi M, van Rensen L, Geddes DM, et al: Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. Thorax 2000;55:205-209.
36. Montuschi P, Collins J, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov S, et al: Exhaled 8-isoprostane as an in vivo biomarker on lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 2000;162:1175-1177.
37. 4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD. Thorax 2003;58:294-298.
38. Kharitonov SA, Rajakulasingam K, O'Con - nor B, Durham SR, Barnes PJ: Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids. J Allergy Clin Immunol 1997;99:58-64.
39. Aronsson D, Tufvesson E, Bjermer L: Allergic rhinitis with or without concomitant asthma: difference in perception of dyspnoea and levels of fractional exhaled nitric oxide. Clin Exp Allergy 2005;35:1457-1461.
40. Alvarez MJ, Olaguibel JM, Garcia BE, Rodriquez A, Tabar AI, Urbiola E: Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy 2000;55:355-356.
41. Beeh KM, Beier J, Kornmann O, Meier C, Taeumer T, Buhl R: A single nasal allergen challenge increases induced sputum inflammatory markers in non-asthmatic subjects with seasonal allergic rhinitis: correlation with plasma interleukin-5. Clin Exp Allergy 2003;33:475-482.
42. Marcucci F, Sensi LG, Migali E, Coniglio G: Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen- allergic rhinitis and asthma. Allergy 2001;56:231-236.
43. Bisgaard H, Gronborg H, Mygind N, Dahl R, Lindqvist N, Venge P: Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990;85:891-895.
44. Sandrini A, Ferreira IM, Jardim JR, Zamel N, Chapman KR: Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis. J Allergy Clin Immunol 2003;111:313-320.